Magnesium Citrate vs Glycinate for Constipation: The 2026 iHerb Guide for GLP-1 Users

The Constipation Crisis That Nobody Saw Coming

It is the side effect that rarely makes the headlines. While the medical establishment has spent the past three years celebrating GLP-1 receptor agonists — Ozempic, Wegovy, Mounjaro — as transformative tools for weight loss and diabetes management, a quieter epidemic has been building in gastroenterology clinics across the United States: chronic, drug-induced constipation affecting a significant minority of the now tens of millions of GLP-1 users.

In October 2025, the FDA formally amended Ozempic’s warning label to include “severe constipation including fecal impaction” as a listed adverse reaction — an acknowledgment that what patients had been reporting for years was real, serious, and clinically documented. Research published in Annals of Internal Medicine analyzing over 200,000 patient records confirmed that GLP-1 receptor agonists carry a materially higher risk of serious gastrointestinal complications compared to other drug classes, with Ozempic users facing roughly a 21% elevated risk.

Into this gap, one supplement has emerged as both a talking point in online GLP-1 communities and a genuine subject of clinical interest: magnesium. Specifically, the debate over Magnesium Citrate vs Glycinate for Constipation — two forms of the same mineral with fundamentally different mechanisms, different price points, and very different answers to the question of who they are actually for. This is our investigation.

Before we get to the products, we need to understand the biology. Choosing the wrong form of magnesium is not just ineffective — for someone already dealing with the nausea and GI turbulence of Ozempic, it can actively make things worse.

The Science of Relief: How Citrate and Glycinate Work Differently

All magnesium supplements deliver the same essential mineral. What differs is the carrier molecule — and that carrier determines almost everything: how fast the magnesium is absorbed, how much remains in the gut, and whether the result is a bowel movement or simply better sleep.

Magnesium is the fourth most abundant mineral in the human body, involved in over 300 enzymatic reactions. It regulates muscle and nerve function, blood glucose, blood pressure, and protein synthesis. Yet national nutrition surveys consistently find that approximately 48% of American adults consume less than the recommended dietary allowance — a figure documented in NHANES data and confirmed by the Dietary Guidelines Advisory Committee. For people on GLP-1 medications who are eating substantially less food overall, this gap widens further.

Magnesium Citrate: The Gut’s Osmotic Engineer

Magnesium citrate is magnesium bound to citric acid. When it reaches the intestines, it behaves as an osmotic laxative: it draws water from surrounding tissues into the bowel, increasing intestinal fluid volume, softening hardened stool, and stimulating the wave-like muscle contractions — peristalsis — that move waste toward the exit. For most people, a 200–400 mg dose produces a bowel movement within 30 minutes to 6 hours.

This mechanism works precisely because magnesium citrate is moderately absorbed. Enough is taken up by the bloodstream to restore systemic magnesium levels, but enough remains in the intestinal lumen to exert meaningful osmotic pressure. It is the Goldilocks formulation — more laxative than the highly bioavailable glycinate, less aggressive than magnesium hydroxide (Milk of Magnesia), which can cause cramping and urgency.

A 2025 systematic review and meta-analysis published in Antioxidants (PMC12189353) affirmed that magnesium citrate is “particularly favoured for its dual benefits of replenishing magnesium and alleviating constipation.” A randomized study in Magnesium Research (PMID 14596323) found it demonstrated superior bioavailability compared to magnesium oxide, making it effective for both gut action and systemic repletion simultaneously.

Magnesium Glycinate: The Brain-Gut Calmer

Magnesium glycinate is magnesium chelated to glycine, an amino acid. It tells an entirely different story. Because glycine has dedicated amino acid transport pathways in the small intestine, magnesium glycinate is absorbed far more efficiently into the bloodstream — which is precisely what makes it ineffective as a direct laxative. Very little magnesium remains in the gut to draw water in.

What glycinate does instead is work upstream: it restores systemic magnesium status, supports the GABA neurotransmitter system, activates glycine receptors in the brainstem and spinal cord, and has been shown in a 2025 review to possess specific anxiolytic properties. For constipation driven by chronic stress, gut-brain axis dysregulation, or colon muscle tension, glycinate addresses root causes rather than symptoms. But for the mechanically blocked bowel of an Ozempic user whose gastric emptying has been chemically slowed, glycinate alone is not enough.

According to clinical content from Oshi Health, “a highly absorbed form, such as magnesium glycinate, is beneficial for correcting magnesium deficiencies, but it leaves little in the intestine to have its osmotic, and therefore, laxative effects.”

Head-to-Head: The Clinical Distinction

Signs of Magnesium Deficiency: Are You Already Low?

Before deciding which magnesium supplement to take, it is worth asking whether you are already deficient — because the answer changes the calculus. A person who is severely depleted of magnesium needs a form that rapidly restores systemic levels (glycinate or malate), whereas a person who is merely constipated with normal magnesium status primarily needs the osmotic action of citrate.

Magnesium deficiency — clinically termed hypomagnesemia — is widely underdiagnosed because standard serum magnesium tests often appear normal even when intracellular stores are critically depleted. Research published in Nutrition Reviews (Rosanoff et al., 2012, PMID 22364157) documented that approximately 48% of Americans consume less than the RDA for magnesium from food. NHANES data shows that 64% of women aged 51–70 fail to meet their estimated average requirement. A 2018 paper in Open Heart (PMC5786912) described subclinical magnesium deficiency as “a principal driver of cardiovascular disease and a public health crisis.” In the GLP-1 era, these figures are increasingly relevant: patients eating significantly less food are at heightened risk of compounding an already widespread deficit.

Magnesium for Ozempic Constipation: A Clinical Necessity in 2026

To understand why magnesium has become such a critical conversation for GLP-1 users, you need to understand precisely how semaglutide (Ozempic, Wegovy) disrupts normal bowel function — and why it is not a minor inconvenience for the patients experiencing it.

GLP-1 receptor agonists work by slowing gastric emptying — the rate at which food moves from the stomach into the small intestine. This is a designed feature: it creates satiety and moderates blood sugar spikes. But the downstream consequence is that food and waste move more slowly through the entire gut. The colon absorbs more water from stool (because it has more time to do so), producing harder, drier fecal matter. Reduced food intake — another intentional effect — means less dietary fiber and reduced bulk in the intestinal tract, further slowing transit time.

Research published in PMC (PMC10213739) found that constipation incidence among GLP-1 users is “positively correlated with the duration of therapy (r² = 0.8–0.9)” — meaning the longer you take Ozempic, the more likely the problem becomes. The FDA’s October 2025 label update for Ozempic explicitly added “severe constipation including fecal impaction” to its listed adverse reactions. Constipation is reported in approximately 10–20% of patients taking GLP-1 weight-loss drugs, with real-world prevalence likely higher during dose escalation phases.

Meanwhile, GLP-1 users face double jeopardy with their magnesium status. GoodRx’s clinical pharmacy team notes that the vomiting and reduced appetite associated with GLP-1 medications can deplete magnesium and potassium levels. Older adults and those with Type 2 diabetes — the core Ozempic demographic — already have statistically higher rates of magnesium deficiency. This is why physicians are increasingly treating magnesium supplementation not as optional but as part of standard GLP-1 supportive care. For related guidance, see our guide to fiber supplements for constipation — a complementary intervention many clinicians recommend alongside magnesium.

⚠ Safety Note for GLP-1 Users: There is no known drug interaction between magnesium supplements and injectable GLP-1 receptor agonists like Ozempic or Wegovy. However, if you take oral semaglutide (Rybelsus), separate your magnesium supplement by at least 30 minutes to avoid potential absorption interference. Patients with kidney disease or impaired renal function should consult their physician before taking any magnesium supplement, as the kidneys regulate magnesium excretion.

The GLP-1 Magnesium Protocol: What Integrative Practitioners Recommend

Morning: Magnesium Citrate (200–400 mg with breakfast). The mild osmotic effect supports regular bowel movements early in the day, working synergistically with the body’s natural cortisol-driven morning motility window. Citric acid also participates in the Krebs energy cycle, providing a subtle metabolic boost relevant to patients managing blood sugar.

Evening: Magnesium Glycinate (200–400 mg, 30–60 minutes before bed). The glycine component promotes sleep onset and quality — clinically important for GLP-1 users, for whom poor sleep impairs the weight-loss benefits of the medication. Overnight, it corrects systemic magnesium deficiency and supports nervous system recovery.

Fella Health’s clinical guide for GLP-1 users confirms: “Given that nausea, vomiting, diarrhea, and constipation are common adverse effects of GLP-1 medications — particularly during dose titration — selecting a magnesium supplement that does not exacerbate these symptoms is clinically prudent.” Glycinate wins on tolerability. Citrate wins on bowel results. Both win when used together.

Best Magnesium for Constipation on iHerb: Top 3 iTested Products (2026)

iHerb uses an independent third-party lab verification program called iTested — testing products via accredited labs including ABC Testing, Eurofins, and Alkemist every 6 months for label accuracy, microbial safety, and heavy metal content. This is the standard we used to filter our recommendations.

Expert Dosage Guide: What Physicians Recommend in 2026

The NIH Office of Dietary Supplements sets the RDA for magnesium at 400–420 mg/day for adult men and 310–320 mg/day for adult women. The tolerable upper intake level (UL) for supplemental magnesium is 350 mg/day — this applies to supplement intake only and does not count dietary magnesium from food. Exceeding the UL increases the risk of osmotic diarrhea and, in susceptible individuals, more serious electrolyte disturbances.

⚠ Drug Interaction Alert: Magnesium can reduce the absorption of certain oral antibiotics (tetracyclines, fluoroquinolones like ciprofloxacin) and bisphosphonates. Separate magnesium supplementation from these medications by at least 2–4 hours. For oral semaglutide (Rybelsus), take magnesium supplements at least 30 minutes after the morning dose. Magnesium may also modestly lower blood pressure — patients on antihypertensive medications should inform their doctor before beginning supplementation.

Side Effects and Safety Considerations

Magnesium is among the safest supplements available when used within recommended limits, but adverse effects are possible — particularly at higher doses or in specific populations. Understanding the risk profile of each form is essential before beginning supplementation, especially for GLP-1 users whose GI systems are already under stress.

Who Should Avoid Magnesium Supplementation Without Medical Supervision

Patients with chronic kidney disease (CKD) or reduced renal function should approach magnesium supplementation only under physician supervision. Healthy kidneys excrete excess magnesium efficiently; impaired kidneys cannot, and magnesium accumulation can lead to hypermagnesemia — a potentially serious condition characterized by low blood pressure, reduced reflexes, cardiac irregularities, and in severe cases, respiratory depression. This risk is particularly relevant for elderly patients and those with diabetic nephropathy — two populations that overlap heavily with the GLP-1 user base.

Additionally, patients taking potassium-sparing diuretics or digoxin (a heart medication) should seek physician guidance before combining magnesium supplementation, as combined electrolyte changes and drug interactions may warrant monitoring.